🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 38% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

6 Tablet(s) Serving Size
30 Servings
Other Combinations Product Type
38% Evidence Coverage

Supplement Facts — Evidence Check

Calories
25 {Calories}
0.8 mg (4% DV)
✅ Within RDA (0.1× RDA of 14 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 0.8mg UL 35mg
2992 mcg (997% DV)
📊 99.7× RDA — above typical dose 📚 26 studies (Tier A: 0, B: 11)
RDA 0.03mg This product: 2.992mg
Calcium
77 mg (7% DV)
68 mg (17% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 68mg
9 mg (60% DV)
✅ Within RDA (0.8× RDA of 11 mg) 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 9mg UL 40mg
90 mcg (129% DV)
✅ 1.6× RDA — within safe limits 📚 172 studies (Tier A: 0, B: 67)
RDA 0.055mg This product: 0.09mg UL 0.4mg
0.2 mg (10% DV)
✅ Within RDA (0.2× RDA of 0.9 mg) 📚 36 studies (Tier A: 0, B: 11)
RDA 0.9mg This product: 0.2mg UL 10mg
1.7 mg (85% DV)
✅ Within RDA (0.7× RDA of 2.3 mg) 📚 8 studies — no high-quality reviews
RDA 2.3mg This product: 1.7mg UL 11mg
110 mcg (92% DV)
📊 3.1× RDA — above typical dose 📚 197 studies (Tier A: 1, B: 55)
RDA 0.035mg This product: 0.11mg
58 mcg (77% DV)
✅ 1.3× RDA — within safe limits 📚 2 studies — no high-quality reviews
RDA 0.045mg This product: 0.058mg UL 2mg
Bitter melon extract
450 mg
Gymnema extract
450 mg
📊 Market median: 260.0mg (249 products) 📚 156 studies (Tier A: 4, B: 61)
This product: 300mg
📊 Market median: 250.0mg (562 products) 📚 53 studies (Tier A: 0, B: 19)
This product: 300mg
Indian kino tree extract
300 mg
300 mg
📊 Market median: 500.0mg (283 products) 📚 173 studies (Tier A: 0, B: 62)
This product: 300mg
📊 Market median: 300.0mg (214 products) 📚 23 studies (Tier A: 0, B: 6)
This product: 300mg
295 mg
📊 Market median: 500.0mg (19 products)
This product: 295mg
Luteolin
268 mg
235 mg
📊 Market median: 550.0mg (217 products) 📚 29 studies (Tier A: 0, B: 5)
This product: 235mg
Banaba extract
200 mg
Betain HCL
178 mg
120 mg
📊 Market median: 200.0mg (136 products) 📚 3 studies — no high-quality reviews
This product: 120mg
Myricetin
105 mg
📊 Market median: 200.0mg (198 products) 📚 6 studies — no high-quality reviews
This product: 100mg
Amylase
60 mg
Lipase
60 mg
MSM
60 mg
📊 Market median: 1000.0mg (2 products)
This product: 60mg
📊 Market median: 500.0mg (76 products)
Median 500.0mg This product: 30mg
Piperine
28 mg
Tungsten
1.1 mg

Other Ingredients

Microcrystalline Cellulose Dextrose Enteric Coating Maltodextrin Silicon Dioxide Sodium Carboxymethyl Cellulose

Label Claims — Verification

All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Directions For Use Adults: 6 tablets per day For optimal results split into 2 doses per day; first thing in the morning and around mid to late afternoon.

🧪 Formulation Notes

Contains ingredients derived from peanut

Does not contain dairy, gluten, soy or shellfish

With Bitter Melon and Gymnema 450 mg of each per serving

Additional Information

Enteric coated

BEST QUALITY GUARANTEE

Product of New Zealand

Store in a cool, dry place.

L1029-7

love life. live life.

Batch number: Manufactured: Use by date:

Product Details

DSLD Entry Date 2013-01-25
Product Type Other Combinations
Form Tablet or Pill
Brand Xtendlife
DSLD ID 17016
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →